Abstract
A large number of scalp disorders may destroy the hair follicles and result in cicatricial alopecia. These include diseases that primarily affect the hair follicles as well as diseases that affect the dermis and secondarily cause follicular destruction. Once established, cicatricial alopecia is a permanent condition that cannot be reversed by treatment. The differential diagnosis between the diseases that cause cicatricial alopecia requires a pathological examination. The site of biopsy is crucial for pathological diagnosis and can be better selected using dermoscopy. Current treatment options of primary cicatricial alopecia are limited as the precise mechanisms that trigger the diseases are still unknown.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abeck D, Korting HC, Braun-Falco O. Folliculitis decalvans. Long lasting response to combined therapy with fusidic acid and zinc. Acta Derm Venereol (Stockh). 1992;72:143–5.
Bellet JS, Kaplan AL, Selim MA, Olsen EA. Keratosis follicularis spinulosa decalvans in a family. J Am Acad Dermatol. 2008;58(3):499–502.
Etoh M, Jinnin M, Makino K, Yamane K, Nakayama W, Aoi J, Honda N, Kajihara I, Makino T, Fukushima S, Ihn H. microRNA-7 down-regulation mediates excessive collagen expression in localized scleroderma. Arch Dermatol Res. 2013;305(1):9–15.
Kittridge A, Haught JM, English JC. Alopecia areata mimicking pseudopelade of Brocq. Cutis. 2010;86(4):187–9.
Makino K, Jinnin M, Hirano A, Yamane K, Eto M, Kusano T, Honda N, Kajihara I, Makino T, Sakai K, Masuguchi S, Fukushima S, Ihn H. The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma. J Immunol. 2013;190(8):3905–15.
Powell JJ, Dawber RPR. Successful treatment regime for folliculitis decalvans despite uncertainty of all aetiological factors. Br J Dermatol. 2001;144:428–9.
Powell JJ, Dawber RPR, Gatter K. Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings. Br J Dermatol. 1999;140:328–33.
Yu M, Bell RH, Ross EK, Lo BK, Isaac-Renton M, Martinka M, Haegert A, Shapiro J, McElwee KJ. Lichen planopilaris and pseudopelade of Brocq involve distinct disease associated gene expression patterns by microarray. J Dermatol Sci. 2010;57(1):27–36.
Further Reading
Alcántara González J, Boixeda P, Truchuelo Díez MT, Fleta Asín B. Keratosis pilaris rubra and keratosis pilaris atrophicans faciei treated with pulsed dye laser: report of 10 cases. J Eur Acad Dermatol Venereol. 2011;25(6):710–4.
Alecu M, Geleriu L, Coman G, Galatescu L. The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis. Rom J Intern Med. 1998;36(3–4):251–9.
Al-Mutairi N, El-Khalawany M. Clinicopathological characteristics of lichen planus pigmentosus and its response to tacrolimus ointment: an open label, non-randomized, prospective study. J Eur Acad Dermatol Venereol. 2010;24(5):535–40.
Aten E, Brasz LC, Bornholdt D, Hooijkaas IB, Porteous ME, Sybert VP, Vermeer MH, Vossen RH, van der Wielen MJ, Bakker E, Breuning MH, Grzeschik KH, Oosterwijk JC, den Dunnen JT. Keratosis follicularis spinulosa decalvans is caused by mutations in MBTPS2. Hum Mutat. 2010;31(10):1125–33.
Baibergenova A, Walsh S. Use of pioglitazone in patients with lichen planopilaris. J Cutan Med Surg. 2012;16(2):97–100.
Castaño-Suárez E, Romero-Maté A, Arias-Palomo D, Borbujo J. Photodynamic therapy for the treatment of folliculitis decalvans. Photodermatol Photoimmunol Photomed. 2012;28(2):102–4.
Cavazzana I, Sala R, Bazzani C, Ceribelli A, Zane C, Cattaneo R, Tincani A, Calzavara-Pinton PG, Franceschini F. Treatment of lupus skin involvement with quinacrine and hydroxychloroquine. Lupus. 2009;18(8):735–9.
Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol. 2007;57(1):47–53.
Chiang C, Sah D, Cho BK, Ochoa BE, Price VH. Hydroxychloroquine and lichen planopilaris: efficacy and introduction of Lichen Planopilaris Activity Index scoring system. J Am Acad Dermatol. 2010;62(3):387–92.
Consorti G, Tieghi R, Clauser LC. Frontal linear scleroderma: long-term result in volumetric restoration of the fronto-orbital area by structural fat grafting. J Craniofac Surg. 2012;23(3):e263–5.
Dubost-Brama A, Delaporte E, Alfandari S, Piette F, Bergoend H. Folliculite disséquante du cuir chevelu: efficacité de l’isotrétinoïne. Ann Dermatol Venereol. 1994;121:328–30.
Duteille F, Le Fourn B, Hepner Lavergne D, Pannier M. The limitation of primary excision of cicatricial alopecia: a report of 63 patients. Ann Plast Surg. 2000;45:145–9.
Edwards KR, Burke WA. Treatment of localized discoid lupus erythematosus with tazarotene. J Am Acad Dermatol. 1999;41(6):1049–50.
Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001;159:237–43.
Georgala S, Katoulis AC, Befon A, Danopoulou I, Georgala C. Treatment of postmenopausal frontal fibrosing alopecia with oral dutasteride. J Am Acad Dermatol. 2009;61(1):157–8.
González-Sixto B, García-Doval I, Oliveira R, Posada C, García-Cruz MA, Cruces M. Quinacrine in the treatment of cutaneous lupus erythematosus: practical aspects and a case series. Actas Dermosifiliogr. 2010;101(1):54–8.
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin-4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol. 1997;24(2):328–32.
Hasegawa M, Sato S, Nagaoka T, Fujimoto M, Takehara K. Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology. 2003;207(2):141–7.
Hemmati I, Otberg N, Martinka M, Alzolibani A, Restrepo I, Shapiro J. Discoid lupus erythematosus presenting with cysts, comedones, and cicatricial alopecia on the scalp. J Am Acad Dermatol. 2009;60(6):1070–2.
Inamo Y, Ochiai T. Successful combination treatment of a patient with progressive juvenile localized scleroderma (Morphea) using imatinib, corticosteroids, and methotrexate. Pediatr Dermatol. 2013;30:e191–3.
Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Panelius J, Hasan T, Julkunen H, Padyukov L, Kvarnström M, Wahren-Herlenius M, Nyberg F, D’Amato M, Kere J, Saarialho-Kere U. Polymorphisms of the ITGAM gene confer higher risk of discoid cutaneous than of systemic lupus erythematosus. PLoS One. 2010;5(12):e14212.
Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, Mirmirani P. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol. 2009;129(5):1243–57.
Katoulis A, Georgala S, Bozi E, Papadavid E, Kalogeromitros D, Stavrianeas N. Frontal fibrosing alopecia: treatment with oral dutasteride and topical pimecrolimus. J Eur Acad Dermatol Venereol. 2009;23(5):580–2.
Kossard S, Lee MS, Wilkinson B. Postmenopausal frontal fibrosing alopecia: a variant of lichen planopilaris. J Am Acad Dermatol. 1997;36:59–66.
Kreuter A, Hyun J, Stücker M, Sommer A, Altmeyer P, Gambichler T. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol. 2006;54(3):440–7.
Kunte C, Loeser C, Wolff H. Folliculitis spinulosa decalvans: successful therapy with dapsone. J Am Acad Dermatol. 1998;39:891–993.
Lencastre A, Tosti A. Images in clinical medicine. A receding hairline. N Engl J Med. 2013;369(2):e2.
Madani S, Trotter MJ, Shapiro J. Pseudopelade of Brocq in beard area. J Am Acad Dermatol. 2000;42:895–6.
Matard B, Meylheuc T, Briandet R, Casin I, Assouly P, Cavelier-Balloy B, Reygagne P. First evidence of bacterial biofilms in the anaerobe part of scalp hair follicles: a pilot comparative study in folliculitis decalvans. J Eur Acad Dermatol Venereol. 2013;27(7):853–60.
Mihaljević N, van den Driesch P. Successful use of infliximab in a patient with recalcitrant folliculitis decalvans. J Dtsch Dermatol Ges. 2012;10(8):589–90.
Mirmirani P, Karnik P. Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist. Arch Dermatol. 2009;145(12):1363–6.
Miteva M, Tosti A. Dermoscopy guided scalp biopsy in cicatricial alopecia. J Eur Acad Dermatol Venereol. 2012;26:1468–3083. 2012.
Navarini AA, Kolios AG, Prinz-Vavricka BM, Haug S, Trüeb RM. Low-dose excimer 308-nm laser for treatment of lichen planopilaris. Arch Dermatol. 2011;147(11):1325–6.
Pai VV, Kikkeri NN, Sori T, Dinesh U. Graham-little piccardi lassueur syndrome: an unusual variant of follicular lichen planus. Int J Trichology. 2011;3(1):28–30.
Parikh N, Choi J, Li M, Sharma R, Fernandez-Peñas P. Squamous cell carcinoma arising in a recent plaque of discoid lupus erythematous, in a sun-protected area. Lupus. 2010;19(2):210–2.
Piraccini BM, Vincenzi C, Lorenzi S, Jorizzo M, Tosti A. Oral calcitriol in the treatment of scleroderma “en coupe de sabre”. J Dermatol Treat. 2000;11:207–8.
Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, Deng Y, Simms R, Lubberts E, Lafyatis R. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One. 2009;4(6):e5903.
Richard G, Harth W. Keratosis follicularis spinulosa decalvans. Hautarzt. 1993;44:529–34.
Rodríguez-Lojo R, Pozo JD, Barja JM, Piñeyro F, Pérez-Varela L. Keratosis pilaris atrophicans: treatment with intense pulsed light in four patients. J Cosmet Laser Ther. 2010;12(4):188–90.
Samrao A, Chew AL, Price V. Frontal fibrosing alopecia: a clinical review of 36 patients. Br J Dermatol. 2010;163(6):1296–300.
Spencer LA, Hawryluk EB, English 3rd JC. Lichen planopilaris: retrospective study and stepwise therapeutic approach. Arch Dermatol. 2009;145(3):333–4.
Stefanaki C, Stefanaki K, Kontochristopoulos G, Antoniou C, Stratigos A, Nicolaidou E, Gregoriou S, Katsambas A. Topical tacrolimus 0.1 % ointment in the treatment of localized scleroderma. An open label clinical and histological study. J Dermatol. 2008;35(11):712–8.
Su O, Onsun N, Onay HK, Erdemoglu Y, Ozkaya DB, Cebeci F, Somay A. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma. Int J Dermatol. 2011;50(8):1006–13.
Sugano M, Shintani Y, Kobayashi K, Sakakibara N, Isomura I, Morita A. Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus. J Dermatol. 2006;33(12):887–91.
Terao M, Matsui S, Katayama I. Two cases of refractory discoid lupus erythematosus successfully treated with topical tocoretinate. Dermatol Online J. 2011;17(4):15.
Torok KS, Arkachaisri T. Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. J Rheumatol. 2012;39(2):286–94.
Tosti A, Torres F, Misciali C, Vincenzi C, Starace M, Miteva M, Romanelli P. Follicular red dots: a novel dermoscopic pattern observed in scalp discoid lupus erythematosus. Arch Dermatol. 2009;145(12):1406–9.
Walker JL, Smith HR, Lun K, Griffiths WA. Improvement of folliculitis decalvans following shaving of the scalp. Br J Dermatol. 2000;142:1245–6.
Wenzel J, Wörenkämper E, Freutel S, Henze S, Haller O, Bieber T, Tüting T. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol. 2005;205(4):435–42.
Wenzel J, Uerlich M, Wörrenkämper E, Freutel S, Bieber T, Tüting T. Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA. Br J Dermatol. 2005;153(5):1011–5.
Zinkernagel MS, Trueb RM. Fibrosing alopecia in a pattern distribution. Arch Dermatol. 2000;136:205–11.
Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, Martino S, Gerloni V, Vittadello F, Martini G, Zulian F, Vallongo C, Patrizi A, Belloni-Fortina A, Cutrone M, Alessio M, Martino S, Gerloni V, Vittadello F, Martini G. A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). J Am Acad Dermatol. 2012;67(6):1151–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Tosti, A., Maranda, E.L., Piraccini, B.M. (2015). Cicatricial Alopecia. In: Katsambas, A.D., Lotti, T.M., Dessinioti, C., D’Erme, A.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-45139-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-662-45139-7_15
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-45138-0
Online ISBN: 978-3-662-45139-7
eBook Packages: MedicineMedicine (R0)